It’s been a busy week for biotech and healthcare conferences. Drugmakers big and small have been making the rounds, answering questions about their current status and future prospects. Celgene Corporation (NASDAQ:CELG) is no exception.
Bob Kellogg, Celgene’s CFO, fielded questions on Wednesday at the Baird Global Healthcare Conference in New York. And the discussion focused less on financial matters than on the big picture of where Celgene is and where it’s headed. Here are five things you’ll want to know from Celgene’s latest presentation.
